These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1578524)

  • 1. Pulmonary manifestations of scleroderma.
    Arroliga AC; Podell DN; Matthay RA
    J Thorac Imaging; 1992 Mar; 7(2):30-45. PubMed ID: 1578524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
    Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
    Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung impairment in scleroderma.
    Piorunek T; Kuznar-Kaminska B; Cofta S; Batura-Gabryel H; Poplawski D; Majewski D; Puszczewicz M; Wysocka E
    Adv Exp Med Biol; 2013; 755():149-54. PubMed ID: 22826062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-pulmonary involvement in systemic sclerosis: A study at a tertiary care center.
    Arakkal G; Chintagunta SR; Chandika V; Damarla SV; Manchala S; Kumar BU
    Indian J Dermatol Venereol Leprol; 2017; 83(6):677-682. PubMed ID: 29035287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung disease in systemic sclerosis (scleroderma).
    Bolster MB; Silver RM
    Baillieres Clin Rheumatol; 1993 Feb; 7(1):79-97. PubMed ID: 8519079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary involvement of scleroderma presenting with nodules].
    Kıvanç T; Ekici Z; Yılmaz S; Oner Eyüboğlu F
    Tuberk Toraks; 2012; 60(4):370-4. PubMed ID: 23289468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.
    Silver RM; Metcalf JF; Stanley JH; LeRoy EC
    Arthritis Rheum; 1984 Nov; 27(11):1254-62. PubMed ID: 6497920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of scleroderma lung disease.
    Highland KB; Garin MC; Brown KK
    Semin Respir Crit Care Med; 2007 Aug; 28(4):418-29. PubMed ID: 17764059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
    Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
    Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in scleroderma.
    White B
    Rheum Dis Clin North Am; 2003 May; 29(2):371-90. PubMed ID: 12841300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.
    White B; Moore WC; Wigley FM; Xiao HQ; Wise RA
    Ann Intern Med; 2000 Jun; 132(12):947-54. PubMed ID: 10858177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung impairment in systemic sclerosis].
    Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
    Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary involvement in systemic sclerosis (scleroderma).
    Steen VD; Owens GR; Fino GJ; Rodnan GP; Medsger TA
    Arthritis Rheum; 1985 Jul; 28(7):759-67. PubMed ID: 4015723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
    Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
    Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis.
    Panigada S; Ravelli A; Silvestri M; Granata C; Magni-Manzoni S; Cerveri I; Dore R; Tomà P; Martini A; Rossi GA; Sacco O
    Pediatr Pulmonol; 2009 Dec; 44(12):1226-34. PubMed ID: 19911363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.